Historical record - last NADAC effective date: 7/1/2024
Product Information
TIROSINT 25 MCG CAPSULE is a brand product labeled by IBSA Pharma Inc., priced at $4.4990 per EA under NDC 71858001004. Its NADAC has been published 296 times since Feb 6, 2019.
FDA first approved this application on Oct 13, 2006.
The High Outlier badge above means this manufacturer's average price in the levothyroxine sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 ug/1
Manufacturer
IBSA Pharma Inc.NDC
71858001004
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
7/1/2024
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA021924FDA Approved
10/13/2006
On Market Since
12/1/2018
Pharmacological Classes
Price Statistics
The NADAC for TIROSINT 25 MCG CAPSULE has been published 296 times since Feb 6, 2019, and over the history we have for it it has risen 9.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4990 per EA |
|---|---|
| All-time high | $4.4990 (Oct 2, 2024) |
| All-time low | $4.0988 (May 22, 2019) |
| Median price | $4.2626 |
| Average price | $4.2659 |
| Largest weekly change | +4.0% (Dec 25, 2019) |
| Weeks tracked | 296 |
| Tracking since | Feb 6, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+2.3%
5Y
+5.2%
All
+9.3%
Last surveyed Oct 2, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 47% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TIROSINT 25 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TIROSINT 25 MCG CAPSULE, manufactured by IBSA Pharma Inc., is $4.4990 per EA (NDC 71858001004), effective Oct 2, 2024.
How has the price of TIROSINT 25 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for TIROSINT 25 MCG CAPSULE has risen 9.3%. It has been tracked across 296 weekly CMS publications since Feb 6, 2019.
What are the highest and lowest recorded NADAC prices for TIROSINT 25 MCG CAPSULE?
Since Feb 6, 2019, the NADAC for TIROSINT 25 MCG CAPSULE has ranged from a low of $4.0988 (May 22, 2019) to a high of $4.4990 (Oct 2, 2024), with a median of $4.2626 per EA.
Are there cheaper alternatives to TIROSINT 25 MCG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVOTHYROXINE 25 MCG CAPSULE, is $2.3629 per EA — about 47% below TIROSINT 25 MCG CAPSULE.
Who manufactures TIROSINT 25 MCG CAPSULE?
TIROSINT 25 MCG CAPSULE (NDC 71858001004) is labeled by IBSA Pharma Inc., and CMS classifies it as a brand product.